Vivos Adds Nutraceuticals to Address Oxidative Stress as Part of OSA Treatment
Summary: Vivos Therapeutics has partnered with Cellev8 Nutrition to enhance its obstructive sleep apnea (OSA) treatment offerings by introducing nutraceuticals that target oxidative stress. This collaboration combines Vivos’ FDA-cleared oral appliances with Cellev8’s antioxidant-rich formulations, aiming to address oxidative stress associated with OSA and provide a more holistic approach to patient care. Key Takeaways: Complementary…